Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response

Rolf P. Kreutz, Perry Nystrom, Yvonne Kreutz, Jia Miao, Zeruesenay Desta, Jeffrey A. Breall, Lang Li, Chien Wei Chiang, Richard Kovacs, David A. Flockhart, Yan Jin

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


Background: The metabolic activation of clopidogrel is a two-step process. It has been suggested that paraoxonase-1 (PON1) is a rate-limiting enzyme in the conversion of 2-oxo- clopidogrel to an active thiol metabolite. Conflicting results have been reported in regard to (1) the association of a common polymorphism of PON1 (Q192R) with reduced rates of coronary stent thrombosis in patients taking clopidogrel and (2) its effects on platelet inhibition in patient populations of European descent. Methods: Blood samples from 151 subjects of mixed racial background with established coronary artery disease and who received clopidogrel were analyzed. Platelet aggregation was determined with light transmittance aggregometry and VerifyNow® P2Y12 assay. Genotyping for cytochrome P450 2C19 (CYP2C19)*2 and *3 and PON1 (Q192R) polymorphisms was performed. Results: Carriers of CYP2C19*2 alleles exhibited lower levels of platelet inhibition and higher on-treatment platelet aggregation than noncarriers. There was no significant difference in platelet aggregation among PON1 Q192R genotypes. Homozygous carriers of the wild-type variant of PON1 (QQ192) had similar on-treatment platelet reactivity to carriers of increasedfunction variant alleles during maintenance clopidogrel dosing, as well as after administration of a clopidogrel 600 mg loading dose. Conclusion: CYP2C19*2 allele is associated with impaired platelet inhibition by clopidogrel and high on-treatment platelet aggregation. PON1 (Q192R) polymorphism does not appear to be a significant determinant of clopidogrel response.

Original languageEnglish (US)
Pages (from-to)13-20
Number of pages8
JournalClinical Pharmacology: Advances and Applications
Issue number1
StatePublished - 2012


  • Aggregation
  • Cytochrome P450 enzymes
  • Platelet
  • PON1

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response'. Together they form a unique fingerprint.

Cite this